These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1147 related items for PubMed ID: 22858389

  • 1. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
    Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY.
    J Am Coll Cardiol; 2012 Aug 28; 60(9):861-7. PubMed ID: 22858389
    [Abstract] [Full Text] [Related]

  • 2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.
    J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin.
    Senoo K, Proietti M, Lane DA, Lip GY.
    Am J Med; 2016 Jun 10; 129(6):600-7. PubMed ID: 26482233
    [Abstract] [Full Text] [Related]

  • 4. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
    Lip GY, Frison L, Halperin JL, Lane DA.
    J Am Coll Cardiol; 2011 Jan 11; 57(2):173-80. PubMed ID: 21111555
    [Abstract] [Full Text] [Related]

  • 5. Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project.
    Lip GY, Banerjee A, Lagrenade I, Lane DA, Taillandier S, Fauchier L.
    Circ Arrhythm Electrophysiol; 2012 Oct 11; 5(5):941-8. PubMed ID: 22923275
    [Abstract] [Full Text] [Related]

  • 6. Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study.
    Lip GYH, Lane DA, Buller H, Apostolakis S.
    Chest; 2013 Dec 11; 144(6):1839-1847. PubMed ID: 24009027
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.
    Apostolakis S, Lane DA, Buller H, Lip GY.
    Thromb Haemost; 2013 Nov 11; 110(5):1074-9. PubMed ID: 24048467
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L, Rosenqvist M, Lip GY.
    Eur Heart J; 2012 Jun 11; 33(12):1500-10. PubMed ID: 22246443
    [Abstract] [Full Text] [Related]

  • 9. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr 11; 5(2):312-8. PubMed ID: 22319005
    [Abstract] [Full Text] [Related]

  • 10. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM, Marín F, Roldán V, Valencia J, Manzano-Fernández S, Caballero L, Hurtado JA, Sogorb F, Valdés M, Lip GY.
    Circ Cardiovasc Interv; 2012 Aug 01; 5(4):459-66. PubMed ID: 22787018
    [Abstract] [Full Text] [Related]

  • 11. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.
    Roldán V, Marín F, Fernández H, Manzano-Fernandez S, Gallego P, Valdés M, Vicente V, Lip GYH.
    Chest; 2013 Jan 01; 143(1):179-184. PubMed ID: 22722228
    [Abstract] [Full Text] [Related]

  • 12. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
    O'Brien EC, Simon DN, Thomas LE, Hylek EM, Gersh BJ, Ansell JE, Kowey PR, Mahaffey KW, Chang P, Fonarow GC, Pencina MJ, Piccini JP, Peterson ED.
    Eur Heart J; 2015 Dec 07; 36(46):3258-64. PubMed ID: 26424865
    [Abstract] [Full Text] [Related]

  • 13. Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients.
    Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY.
    J Am Coll Cardiol; 2013 Jan 22; 61(3):386-7. PubMed ID: 23246385
    [No Abstract] [Full Text] [Related]

  • 14. Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin.
    Burgess S, Crown N, Louzada ML, Dresser G, Kim RB, Lazo-Langner A.
    J Thromb Haemost; 2013 Sep 22; 11(9):1647-54. PubMed ID: 23848301
    [Abstract] [Full Text] [Related]

  • 15. Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
    Senoo K, Lip GY.
    Int J Cardiol; 2016 Oct 15; 221():379-82. PubMed ID: 27409565
    [Abstract] [Full Text] [Related]

  • 16. The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants.
    Lip GYH, Skjøth F, Nielsen PB, Kjældgaard JN, Larsen TB.
    Am J Med; 2018 May 15; 131(5):574.e13-574.e27. PubMed ID: 29274754
    [Abstract] [Full Text] [Related]

  • 17. Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Kiviniemi T, Puurunen M, Schlitt A, Rubboli A, Karjalainen P, Vikman S, Niemelä M, Lahtela H, Lip GY, Airaksinen KE.
    Am J Cardiol; 2014 Jun 15; 113(12):1995-2001. PubMed ID: 24793675
    [Abstract] [Full Text] [Related]

  • 18. Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores.
    Proietti M, Rivera-Caravaca JM, Esteve-Pastor MA, Romiti GF, Marin F, Lip GYH.
    J Am Heart Assoc; 2018 Sep 18; 7(18):e009766. PubMed ID: 30371183
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation.
    Yao X, Gersh BJ, Sangaralingham LR, Kent DM, Shah ND, Abraham NS, Noseworthy PA.
    Am J Cardiol; 2017 Nov 01; 120(9):1549-1556. PubMed ID: 28844514
    [Abstract] [Full Text] [Related]

  • 20. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.
    Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Vicente V, Valdés M, Marín F, Lip GYH.
    Thromb Haemost; 2017 Oct 05; 117(10):1848-1858. PubMed ID: 28799620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.